Sinovac Biotech Stock Forward View
| SVA Stock | USD 6.47 0.00 0.00% |
Sinovac Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Sinovac Biotech stock prices and determine the direction of Sinovac Biotech's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Sinovac Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of Sinovac Biotech's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 3.548 | EPS Estimate Current Year (0.11) | EPS Estimate Next Year (0.12) | Wall Street Target Price 3.52 | Quarterly Revenue Growth 3.037 |
Using Sinovac Biotech hype-based prediction, you can estimate the value of Sinovac Biotech from the perspective of Sinovac Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Sinovac Biotech on the next trading day is expected to be 6.47 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Sinovac Biotech after-hype prediction price | USD 6.47 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sinovac Biotech to cross-verify your projections. Sinovac Biotech Additional Predictive Modules
Most predictive techniques to examine Sinovac price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sinovac using various technical indicators. When you analyze Sinovac charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sinovac Biotech Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Sinovac Biotech's financial statements to predict how it will affect future prices.
Cash | First Reported 2001-03-31 | Previous Quarter 1.3 B | Current Value 1.1 B | Quarterly Volatility 2.5 B |
Sinovac Biotech Naive Prediction Price Forecast For the 6th of February
Given 90 days horizon, the Naive Prediction forecasted value of Sinovac Biotech on the next trading day is expected to be 6.47 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Sinovac Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sinovac Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sinovac Biotech Stock Forecast Pattern
| Backtest Sinovac Biotech | Sinovac Biotech Price Prediction | Research Analysis |
Sinovac Biotech Forecasted Value
In the context of forecasting Sinovac Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sinovac Biotech's downside and upside margins for the forecasting period are 6.47 and 6.47, respectively. We have considered Sinovac Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sinovac Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Sinovac Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 54.8121 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Sinovac Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sinovac Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinovac Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sinovac Biotech After-Hype Price Density Analysis
As far as predicting the price of Sinovac Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sinovac Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sinovac Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sinovac Biotech Estimiated After-Hype Price Volatility
In the context of predicting Sinovac Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sinovac Biotech's historical news coverage. Sinovac Biotech's after-hype downside and upside margins for the prediction period are 6.47 and 6.47, respectively. We have considered Sinovac Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sinovac Biotech is very steady at this time. Analysis and calculation of next after-hype price of Sinovac Biotech is based on 3 months time horizon.
Sinovac Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sinovac Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sinovac Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sinovac Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 4 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.47 | 6.47 | 0.00 |
|
Sinovac Biotech Hype Timeline
On the 5th of February Sinovac Biotech is traded for 6.47. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sinovac is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Sinovac Biotech is about 0.0%, with the expected price after the next announcement by competition of 6.47. About 51.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.82. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sinovac Biotech had not issued any dividends in recent years. Considering the 90-day investment horizon the next anticipated press release will be in about 3 days. Check out Historical Fundamental Analysis of Sinovac Biotech to cross-verify your projections.Sinovac Biotech Related Hype Analysis
Having access to credible news sources related to Sinovac Biotech's direct competition is more important than ever and may enhance your ability to predict Sinovac Biotech's future price movements. Getting to know how Sinovac Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sinovac Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ITOS | Iteos Therapeutics | (0.04) | 7 per month | 0.43 | (0.09) | 1.09 | (0.79) | 3.17 | |
| IVVD | Invivyd | (0.01) | 8 per month | 5.64 | 0.02 | 11.11 | (8.57) | 46.37 | |
| SAGE | Sage Therapeutics | 0.06 | 8 per month | 1.70 | 0.04 | 3.61 | (3.48) | 37.83 | |
| RVNC | Revance Therapeutics | 0.01 | 6 per month | 0.00 | (0.08) | 6.38 | (5.97) | 40.39 | |
| BCYP | Big Cypress Acquisition | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| YMAB | Y MAbs Therapeutics | 0.02 | 5 per month | 1.80 | 0.11 | 7.03 | (4.29) | 103.46 | |
| ORTX | Orchard Therapeutics PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIGL | Vigil Neuroscience | 0.01 | 8 per month | 1.63 | 0.12 | 5.09 | (2.49) | 241.38 | |
| GTHX | G1 Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CKPT | Checkpoint Therapeutics | 0.05 | 7 per month | 1.42 | 0.10 | 2.33 | (2.52) | 62.14 |
Other Forecasting Options for Sinovac Biotech
For every potential investor in Sinovac, whether a beginner or expert, Sinovac Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sinovac Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sinovac. Basic forecasting techniques help filter out the noise by identifying Sinovac Biotech's price trends.Sinovac Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sinovac Biotech stock to make a market-neutral strategy. Peer analysis of Sinovac Biotech could also be used in its relative valuation, which is a method of valuing Sinovac Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sinovac Biotech Market Strength Events
Market strength indicators help investors to evaluate how Sinovac Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sinovac Biotech shares will generate the highest return on investment. By undertsting and applying Sinovac Biotech stock market strength indicators, traders can identify Sinovac Biotech entry and exit signals to maximize returns.
Story Coverage note for Sinovac Biotech
The number of cover stories for Sinovac Biotech depends on current market conditions and Sinovac Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sinovac Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sinovac Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sinovac Biotech Short Properties
Sinovac Biotech's future price predictability will typically decrease when Sinovac Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sinovac Biotech often depends not only on the future outlook of the potential Sinovac Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sinovac Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 99.6 M | |
| Cash And Short Term Investments | 11.2 B |
Check out Historical Fundamental Analysis of Sinovac Biotech to cross-verify your projections. For information on how to trade Sinovac Stock refer to our How to Trade Sinovac Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sinovac Biotech. If investors know Sinovac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sinovac Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 3.548 | Earnings Share 0.971 | Revenue Per Share | Quarterly Revenue Growth 3.037 | Return On Assets |
Understanding Sinovac Biotech requires distinguishing between market price and book value, where the latter reflects Sinovac's accounting equity. The concept of intrinsic value - what Sinovac Biotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sinovac Biotech's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sinovac Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sinovac Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sinovac Biotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.